01—Abstract
Summary
Summary of the 8-K filed March 27, 2024. Cited figures are marked; the original filing is the authoritative source.
Laboratory Corporation of America Holdings (now Labcorp Holdings Inc.) filed this Form 8-K on March 27, 2024 under Item 7.01 (Regulation FD Disclosure) to announce the timing of its first-quarter 2024 financial results.
The company will release those results before the market opens on Thursday, April 25, 2024, and will host a conference call and webcast beginning at 9 a.m. ET that day to discuss them. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
The filing itself contains no financial results, guidance, or operating metrics. Its only substantive content is the scheduling of the earnings release and call, along with a replay of the webcast that will be available until April 11, 2025. The filing attaches Exhibit 99.1, a press release dated March 27, 2024, which announces the earnings date and call details and describes Labcorp as a global laboratory services provider with more than 67,000 employees serving clients in approximately 100 countries.
The release also states that the company supported 84%a of new drugs and therapeutic products approved by the FDA in 2023 and performed more than 600 million tests for patients. For investors, the key takeaway is the date and format of the Q1 2024 earnings event. Substantive performance information will come with the April 25, 2024 release and the subsequent discussion on the call.
02—Key points
Key Highlights
- Labcorp will release first-quarter 2024 financial results before the market opens on Thursday, April 25, 2024.
- A conference call and webcast to discuss the results will begin at 9 a.m. ET on April 25, 2024.
- The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
- The webcast is listen-only, and a replay will be available approximately two hours after the live event until April 11, 2025.
- The filing is a Regulation FD disclosure under Item 7.01 and contains no financial results.
- Exhibit 99.1 is a press release dated March 27, 2024 announcing the earnings date and call details.
- The company reports more than 67,000 employees, clients in approximately 100 countries, and 600 million-plus tests performed for patients.
03—Questions
Frequently Asked Questions
When will Labcorp report its first-quarter 2024 financial results?
Labcorp will release its first-quarter 2024 financial results before the market opens on Thursday, April 25, 2024.
How can investors access the earnings call?
The company will host a conference call and webcast beginning at 9 a.m. ET on April 25, 2024. The webcast is live on the Labcorp Investor Relations website. Participants can register there to receive dial-in numbers and a unique PIN, and the company recommends joining 10 minutes before the start.
Where will the earnings materials be published?
The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
Will a replay of the call be available?
Yes. A replay of the webcast will be available approximately two hours after the live event concludes and will remain available until April 11, 2025.
Does this filing disclose first-quarter 2024 results?
No. The filing only announces the date and format of the first-quarter 2024 earnings release and call. Results are expected to be released on April 25, 2024.
04—Continue